HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIA
- 1 March 1977
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 309 (8010) , 497-499
- https://doi.org/10.1016/s0140-6736(77)91366-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- IMMUNOTHERAPY IN THE MANAGEMENT OF ACUTE LEUKAEMIABritish Journal of Haematology, 1976
- QUALITY AND QUANTITY OF SURVIVAL IN ACUTE MYELOID LEUKÆMIAThe Lancet, 1975
- Treatment of acute leukemia in adultsCancer, 1975
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.The Lancet, 1974
- Treatment of Acute Myeloid Leukaemia with Daunorubicin, Cytosine Arabinoside, Mercaptopurine, L‐Asparaginase, Prednisone and Thioguanine: Results of Treatment with Five Multiple‐Drug SchedulesBritish Journal of Haematology, 1974
- Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic responseArchives of internal medicine (1960), 1974
- Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemiaCancer, 1973
- Management of Adult Acute Myelogenous LeukaemiaBMJ, 1973
- The Treatment of Acute Granulocytic Leukemia in AdultsNew England Journal of Medicine, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958